{
    "code": "60001100",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001100",
    "time": "2020-09-25 10:45:01",
    "許可證字號": "衛部菌疫輸字第001100號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/04\/23",
    "發證日期": "108\/04\/23",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000110001",
    "中文品名": "奈維血添注射\/輸注液 480微克\/0.5毫升",
    "英文品名": "Nivestim solution for injection\/infusion 480μg\/0.5mL",
    "適應症": "適應症：\r\n1. 動員造血幹細胞至周邊血中。\r\n2. 促進造血幹細胞移植時嗜中性白血球數的增加。\r\n3. 癌症化學療法所引起之嗜中性白血球減少症。\r\n4. 先天性、特異性嗜中性白血球缺乏症。",
    "劑型": "27D注射液劑",
    "包裝": "每盒100支以下，0.5mL預充填注射針筒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "113\/04\/23",
    "主成分略述": "FILGRASTIM",
    "限制項目": "02輸　入 1D須執行風險管理計畫 91生物相似性藥品",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義路松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FHR0004000  HOSPIRA ZAGREB D.O.O.",
            "製造廠廠址": "Prudnicka cesta 60, 10291, Prigorje Brdovecko, Croatia",
            "製造廠公司地址": "",
            "製造廠國別": "CROATIA",
            "製程": "原料藥及成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000500",
            "成分名稱": "FILGRASTIM",
            "含量描述": "",
            "含量": "0.4800000000",
            "單位": "MG\/UNIT"
        }
    ],
    "仿單外盒": [
        {
            "title": "4. [仿單](衛部菌疫輸_01099、01100)Nivestim LLD Taiwan Filgrastim leaflet_MOH 201711-4-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=001&Type=9"
        },
        {
            "title": "Nivestim-LAB-480mcg-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=007&Type=8"
        },
        {
            "title": "Nivestim 480mcg_syringe blister label_201911-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=006&Type=8"
        },
        {
            "title": "Nivestim 480mcg_inner label_201911-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=005&Type=8"
        },
        {
            "title": "Nivestim 480mcg_carton-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=004&Type=8"
        },
        {
            "title": "Nivestim 480mcg AUS blister label_71003232-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=003&Type=8"
        },
        {
            "title": "Nivestim 480mcg AUS inner label_71003236-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=002&Type=8"
        },
        {
            "title": "Nivestim 480 mcg AUS carton_71003248-108-12-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001100&Seq=001&Type=8"
        }
    ]
}